Sali, Mardhia .
HRN: 03-53-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
CEFUROXIME 500MG (TAB)
02/20/2026
02/27/2026
PO
500mg
BID
Thinly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: